Takuto Fujii

7PUBLICATIONS
8CO-AUTHORS
Molecular targetsMultiphysics flows (incl. multiphase and reacting flows)Clinical pharmacology and therapeuticsPhylogeny and comparative analysisCancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Sep 15, 2026
Cardiac Glycoside 3β-Bufalin Suppresses Cancer Cell Proliferation by Coupling with Na+,K+-ATPase and Volume-Regulated Anion Channel Within Membrane Microdomains.

|Apr 10, 2026
Role of Na+/H+ exchanger 3 in acidification and morphological remodeling of tubulovesicles in gastric parietal cells.

Takuto Fujii, Hayato Shimizu, Pattama Wiriyasermkul

|Feb 27, 2026
Pathophysiological Roles of Two Intracellular P-Type ATPases: The Cancer-Associated Na+,K+-ATPase α3 Isoform and the Parkinson's Disease-Related ATP13A2.

Takuto Fujii, Takahiro Shimizu, Hideki Sakai

|May 11, 2025
Digoxin promotes anoikis of circulating cancer cells by targeting Na+/K+-ATPase α3-isoform.

Yoshihisa Numata, Takuto Fujii, Chihiro Toda

|Apr 02, 2024
Negative regulation of thyroid adenoma-associated protein (THADA) in the cardiac glycoside-induced anti-cancer effect.

Mizuki Katoh, Takuto Fujii, Yoshiaki Tabuchi

|Apr 20, 2023
Parkinson's disease-associated ATP13A2/PARK9 functions as a lysosomal H+,K+-ATPase.

Takuto Fujii, Shushi Nagamori, Pattama Wiriyasermkul

Pageof 2

Frequent Collaborators

6 joint publications

Hideki Sakai

3 joint publications

Takahiro Shimizu

3 joint publications

Tsutomu Fujii

2 joint publications

Shushi Nagamori